Additionally, we observed preservation of normal bone marrow CD34+ cells and clonogenic function at AML-toxic doses of tefinostat in contrast to other HDAC inhibitors used in similar studies where significant increases in acetylation were observed in normal CD34+ cells [32, 33]. This evidence concerns the gene CD34 and acute myeloid leukemia.